UCART-5T4

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameUCART-5T4
Drug Alias NameUCART-5T4
ClassificationBiologics > Protein drugs > Recombinant polypeptideBiologics > Antigen > Tumor antigen
Mechanisms of ActionImmunomodulatorsT lymphocytes modulators
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCellectis Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCellectis Sa
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A